UK's Indivior rises on beating first quarter revenue view

Indivior

24/04/2025 09:05

** Shares of anti-opioid treatment maker Indivior INDV.L rise as much as 6.3% to 738.5p

** Co reports Q1 total net revenue of $266 million, which was above consensus of $243 million, according to Jefferies analysts

** Co also reiterated its FY2025 guidance

** Adds it expects its key product, SUBLOCADE, to grow again in second-half of the year

** Up to Wednesday's close, stock had fallen about 31% so far this year

 (
 Reporting by Simone Lobo in Bengaluru)

 ((Simone.Lobo@thomsonreuters.com; +919920570373;))